WTA
ABBV icon

Washington Trust Advisors’s AbbVie ABBV Stock Holding History

Washington Trust Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.84M Sell
15,278
-1,091
-7% -$235K 0.29% 61
2026
Q1 		$3.56M Buy
16,369
+17
+0.1% +$3.77K 0.29% 62
2025
Q4 		$3.74M Sell
16,352
-397
-2% -$90.4K 0.29% 59
2025
Q3 		$3.88M Sell
16,749
-285
-2% -$58K 0.3% 57
2025
Q2 		$3.16M Sell
17,034
-139
-0.8% -$25.8K 0.26% 60
2025
Q1 		$3.6M Buy
17,173
+6
+0% +$1.17K 0.32% 57
2024
Q4 		$3.05M Buy
17,167
+170
+1% +$31.3K 0.26% 63
2024
Q3 		$3.36M Buy
16,997
+673
+4% +$126K 0.29% 60
2024
Q2 		$2.8M Sell
16,324
-636
-4% -$105K 0.26% 62
2024
Q1 		$3.09M Sell
16,960
-16
-0.1% -$2.76K 0.28% 61
2023
Q4 		$2.63M Buy
16,976
+203
+1% +$29.6K 0.25% 62
2023
Q3 		$2.5M Buy
16,773
+18
+0.1% +$2.64K 0.26% 66
2023
Q2 		$2.26M Sell
16,755
-397
-2% -$58.2K 0.22% 67
2023
Q1 		$2.73M Buy
17,152
+107
+0.6% +$16.4K 0.28% 63
2022
Q4 		$2.75M Sell
17,045
-479
-3% -$73.4K 0.3% 63
2022
Q3 		$2.35M Buy
17,524
+136
+0.8% +$19.5K 0.22% 78
2022
Q2 		$2.66M Sell
17,388
-410
-2% -$62.6K 0.23% 74
2022
Q1 		$2.88M Sell
17,798
-230
-1% -$33.4K 0.2% 78
2021
Q4 		$2.44M Buy
+18,028
New +$2.13M 0.17% 84

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Washington Trust Advisors's ABBV Position: Q2 2026 in Review

Washington Trust Advisors reduced its AbbVie (ABBV) stake by 6.7% in Q2 2026, selling an estimated $235K and leaving 15,278 shares worth $3.84M. The position accounts for 0.29% of the portfolio, ranked #61.

Washington Trust Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.88M in Q3 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Washington Trust Advisors held 15,278 shares of AbbVie worth $3.84M as of Q2 2026.
  • Washington Trust Advisors sold 1,091 AbbVie shares in Q2 2026, an estimated $235K.
  • AbbVie made up 0.29% of Washington Trust Advisors's portfolio in Q2 2026, its #61 holding.
  • Washington Trust Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's AbbVie position peaked at $3.88M in Q3 2025.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.